API has launched its Advisory Committee. With a broad group of expertise from multiple areas of the drug development world our committee includes the following members:

Advisory Committee

LAUNA ASPESLET

CEO, TRIO

BRIAN CORRIGAN

Global Head, Clinical Pharmacology, Pfizer

MATT COFFEY

CEO, Oncolytics

SALMA JUTT

Chief Commercial Officer, Acer Therapeutics

SAILAJA BHASKAR

Executive Director, R&D, Purdue Pharma

ROBERT FOSTER

CEO, ContraVir

JAMIE LUCIEN

Biotech Patent Lawyer

MAJID VAKILYNEJAD

Senior Director, Takeda